Parallel Advisors, LLC Neogenomics Inc Transaction History
Parallel Advisors, LLC
- $4.87 Billion
- Q2 2025
A detailed history of Parallel Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 144 shares of NEO stock, worth $809. This represents 0.0% of its overall portfolio holdings.
Number of Shares
144
Previous 240
40.0%
Holding current value
$809
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding NEO
# of Institutions
276Shares Held
126MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$111 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$80.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$37.8 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$34 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$32.3 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $707M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...